Collectively, these results demonstrate that the anti-colon cancer activity of CyCl achieved by Nrf2 activation resulting in apoptosis is mediated by inhibition of the NF-κB signaling pathway. This evidence concerns the gene NFE2L2 and malignant colon neoplasm.